NCT01461460View on ClinicalTrials.gov

A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 28, 2011

Primary Completion Date

December 23, 2011

Study Completion Date

December 23, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

TR-701 FA 1200 mg

6 tablet of T-701 FA

DRUG

Moxifloxacin 400 mg

1 tablet 400 mg Moxifloxacin

DRUG

TR-701 FA 200 mg plus Placebo

1 tablet of TR-701 FA with 5 tablet placebo

DRUG

Placebo

6 placebo tablets

Trial Locations (1)

75247

Trius Investigator, Dallas

All Listed Sponsors
lead

Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY

NCT01461460 - A Thorough QT Study of TR-701free Acid (FA) in Healthy Subjects | Biotech Hunter | Biotech Hunter